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INTRODUCTION: 
 
               It is a well established fact that psychiatric illness is more 
common among terminally ill patients. End stage renal disease is one 
such clinical condition in which patients are left with only two 
treatment options ,either dialysis procedure or renal transplantation, the 
second option being the ultimate choice.  
Though transplantation offers a solution to overcome painful, 
uncomfortable, time - consuming dialysis procedures, many patients 
are noted to have emotional distress and affective disorders even after 
successful renal transplantation. More common among these are 
depression and anxiety often associated with an impaired quality of life. 
Further the recipients experience many challenges like fear of new 
organ being rejected and the need for strict adherence to 
immunosuppressive medications that may generate distressing side 
effects.  
Several studies analyzed psychiatric morbidity such as 
depression , anxiety between dialysis patients and renal transplant 
recipients. But there are very few studies which compared depression 
and anxiety of the transplant recipients with that of the general 
population.(Alavi, Aliakbarzadeh, & Sharifi, 2009) 
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 In studies conducted previously in this area some studies have 
concluded that anxiety and depression improves after renal 
transplantation because of some improvement in social functioning and 
feeling of psychological well being.(Pascazio et al., 2010) But there are 
also several other studies which had argued the exact controversial 
findings in their results. 
Drug compliance after transplantation is now emerging as a 
health issue affecting patients quality of life in multiple domains. 
Several studies have shown that those patients having emotional 
problems like anxiety, depression, hostility, distress, lack of coping are 
more non compliant after transplantation than those without emotional 
problems. 
 One such research conducted in kidney transplant recipients 
came with a data that 50% of them suffered from anxiety and 25% 
from depression in the post transplantation period ,(Noohi et al., 
2007)though there is less data from Indian studies regarding prevalence. 
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REVIEW OF LITERATURE 
 
CONSULTATION -LIAISON PSYCHIATRY: 
 
 Consultation- liaison describes two interrelated roles of 
psychiatrists. Consultation provides expert opinion about the diagnosis 
and management of a patient when requested by another health 
professional. Liaison does the linking of groups for effective 
collaboration purposes. (Lipowski, 1986) In the current concept, this 
field mediates between patients and members of other clinical team 
with mental health professionals.                
  Liaison psychiatry is the branch of psychiatry which involves 
assessment and treatment of patients in general hospital setup like 
casualty, patients with tendency of deliberate self harm. The Indian 
scenario shows reference from medicine, surgery, superspeciality and 
orthopaedics with psychiatric disorders like anxiety, depression and 
organic brain syndrome , present in about 40 to 50% of  the patients. 
 Though  the Indian published data is limited, most tertiary 
hospitals in India carry out liaison work with various departments like 
neurology, organ transplant, intensive care units and cosmetic surgery 
so as to give comprehensive health services to patients(Parkar & 
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Sawant, 2010). In all probability ,an even more important need of 
research in the area of liaison  psychiatry is to put together a “client 
profile” and develop tailor made services in the most advantageous 
way(Parkar & Sawant, 2010). These services are very well accepted by 
people and reduces stigma related to psychiatric illness. 
 
HISTORY OF ORGAN TRANSPLANTATION: 
               
  Though solid organ and other tissue transplants had been 
attempted from 1900s, only in 1954 the first successful organ 
transplant was carried out by Joseph Murray using an identical twin 
brother as a kidney donor. Even after the successful surgery, routine 
organ transplantation was not possible till the challenge of suppression 
of the immune system was resolved.  
After the development of chemical immunosuppression in the 
early 1960s the first deceased donor kidney, liver, lung, and pancreas 
transplants were performed, followed by the first heart transplant in the 
late 1960s. 
It took nearly  two decades to discover and develop cyclosporine, 
a specific and powerful immunosuppressant drug, providing selective 
immune regulation of T cells without excessive toxicity.  
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The U.S. Food and Drug Administration (FDA) had approved 
cyclosporine for use in solid organ transplantation in the year 1983 and 
this led to an increase in the numbers of transplants ,decrease in 
morbidity of transplant recipients, and increases in the patient survival 
rates in the post transplantation period . 
Especially the number of kidney transplantation for end stage 
renal disease has increased drastically in the last 2 decades. 
 
 
COURSE AND PROGNOSIS 
 
Transplantation is a continuum process demarcated by specific 
phases. The end-stage organ disease heralds the beginning of the 
transplantation process. From pre transplant evaluation at the transplant 
program, to waiting on the list, followed by early and longer term 
recovery and adaptation to life as recipient of new organ, each and 
every phase is significantly linked with different type of life stressors 
and requires skills and resources from patients, caregivers, and the 
mental health professionals caring for them. Psychiatrists are most 
frequently called to evaluate the prospective transplant candidate.  
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PSYCHONEPHROLOGY: 
 
 Psychonephrology is the systematic study of psychiatric effects 
of renal dialysis and kidney transplantation. The pioneers in this field 
of consultation liaison psychiatry are the late Harry Abram ,Denour et 
al ,Atarka Kaplan and Levy Viederman.  
Psychiatric morbidity must be considered similar to other 
postoperative medical and surgical problems. Psychiatrists in this unit 
have to face some difficulty in ruling out organicity from adjustment 
disorder, mood disorder, anxiety disorder (Kornfeld, 2002).  
With the availability of immunosuppressant treatment , the 
feasibility of organ transplantation has increased to a great extent. The 
contribution of consultation liaison psychiatrists  is being required for 
both preoperative assessment and postoperative management. It is 
inferred that in the organ transplantation , the patients who are in need 
of psychosocial help has to be identified and treated , in order to 
improve the outcome as a whole.  
The effects of tacrolimus and cyclosporine has to be mentioned, 
the drugs which are given for immunosuppression to prevent graft 
rejection may also elevate the risk of mood/depressive 
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disorders(Kemper, Spartà, Laube, Miozzari, & Neuhaus, 2003) These 
immunosuppressant treatment interferes with monoaminergic 
transmission.(Shuto et al., 1998) .Such finding have to be considered in 
patients taking cyclosporine for a prolonged period of time. It was 
under research that whether these drugs brings about changes in the 
neurotransmitter acting on the basic circuits of emotions in the brain. 
 
END STAGE RENAL DISEASE AND RENAL 
TRANSPLANTATION  
 
End stage renal disease is a terminally ill condition in which the 
renal function is lost and attained an irreversible stage to recover, 
making the patient permanently depend on either dialysis or 
transplantation. When treating ESRD patients, the realistic goal is not 
cure but maximizing their functioning capacity and well being.  
There are differences in the prevalence of transplantation 
surgeries between countries. This can be explained by the changes 
existing in laws and the differences in utilizing donated organs 
efficiently. In India, the incidence and prevalence of ESRD is 
increasing, which is due to diabetes mellitus and hypertension. Because 
of difficulty in accessing renal transplantation therapy and affordability, 
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more than 90% of the patients with end stage renal disease die within 
months of being diagnosed.(Vettath et al., 2012) 
In India ,the incidence of ESRD is 150/million population ,but 
3.25 renal transplantations are being done per million population from 
live and deceased donors and the remaining population depends on 
maintenance haemodialysis.(Nogueira et al., 2010) 
The life expectancy in India is 66.46 years on an average, which 
is 67.57 for females and 65.46 for males. The GDP growth rate of our 
country as on the year 2010 is US$1050 persons per year, which is 
below the poverty line.  
Our government contributes 0.9% of GDP on health care 
facilities and the contribution from private sectors is 4.3% on an 
average. (Vettath et al., 2012). Inspite of being supported by the 
government, in some countries economic status still plays a 
predominant role in access to health facilities and quality of care. 
 Renal transplantation improves the quality of life in several 
domains for patients but immunosuppressant treatment which includes 
oral steroids and drugs like cyclosporine, tacrolimus is required for 
graft survival, and there comes the problem of affordability and drug 
adherence by the patients. 
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Several explanations have been proposed for the negative impact 
of low socioeconomic status on the self-perceived health status like 
differences in life style, availability of various supportive resources 
and presence of different stressors.  
Renal transplant patients with low income are more likely to 
experience allograft failure than patients with adequate income after a 
period of 5 to 10 years, because of psychological stress and anxiety. 
Several countries have performed studies to trace the various 
psychological factors that affect the quality of life in transplant 
recipients. Various inconsistencies exist in their results, but as a 
general  
psychological factors  
 fear,  
 anger,  
 denial of illness ;  
 
psychosocial factors  
 education,  
 occupation,  
 marital status ,  
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Clinical parameters  
 duration of end stage renal disease,  
 dialysis period prior to transplantation 
 comorbid medical illness ,  
 renal function assessed by serum creatinine value,  
 glomerular filtration rate   
Were found to produce significant change in the quality of life. 
 
 
CLINICAL EVALUATION FOR TRANSPLANTATION: 
    
The major limitation of renal transplantation is the availability, 
of donor organs, the number of wait listed patients outnumber the 
organ donors.  
Therefore, the considerable medical, social, and financial 
resources necessary for successful transplantation; the responsibility of 
transplant recipients; and the involvement of their family and other 
caregivers, careful assessment of transplant candidates and their 
caregivers is required.  
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Evaluations in the pre -transplantation period typically involve 
two components:  
 
                           1) A medical component and  
                           2) A psychosocial assessment. 
 
 
During the medical assessment, patients are evaluated and 
assessed whether there is a definite indication for transplantation based 
on UNOS criteria and to rule out significant medical co morbidities 
like  
diabetes mellitus,  
morbid obesity, or a  
history of malignancy  
that increases the risk for post transplant morbidity and mortality.  
The mental health professional must have knowledge about their 
clinical team's approach to psychosocial issues and have to educate the 
team on the prognosis and treatment of psychiatric disorders.  
Consultation- liaison psychiatrists have dual responsibility in the 
transplant evaluation process, satisfying both the requirements of the 
transplant team as well as the transplant recipient.  
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Simultaneously playing two roles, psychiatrists can both 
advocate for the transplant recipient and communicate and interpret 
back the transplant team's requirements to the recipient. 
 
The details collected during the psychosocial evaluation are 
essential for the complete understanding of the patient by the transplant 
team.  
The patient also receives education on renal transplant-related 
expectations which makes the patient to prepare themselves for the 
procedure and helps in early adaptation during recovery.  
Thus the mental health professional facilitates the development 
of a long-term collaborative relationship necessary between the patient 
and the transplant team.  
Not only addressing the transplant team's concerns and guiding 
the patient eligibility determinations, the pretransplant assessment can 
also be used to develop an individualized treatment plan to prepare the 
patient for transplantation and optimize post transplant outcomes.  
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PATIENT ADAPTATION THROUGH THE TRANSPLANT 
TIME COURSE 
Evaluation and Waiting Period 
 
Patients face adaptive challenges as they move on from the pre- 
to-post transplant course. Even the waiting period is perceived by 
many patients and their families as more psychologically stressful. 
This is more so in the case if patients are newly diagnosed to have 
terminal end-stage renal disease and considering the transplant surgery 
for the first time and decided to lead their future life as a transplant 
recipient.  
The adjustment level of patients at the time of transplant 
evaluation depends on  
• the seriousness of illness,  
• the duration of illness (acute vs. chronic), and  
• anticipation of disease (either positively or negatively)  
• the organ replacement requirement.  
 
Adapting to these new stresses can cause avoidance, denial, 
anxiety and depression. Candidates who are having a living donor can 
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choose the time of their transplant surgery can overcome the 
uncertainty of the wait time for surgery.  
Psychoeducation for patients and families can help them in 
successfully crossing these transition periods and prepare them 
mentally for either transplantation or death. 
 
Peri-operative Period 
 
For patients who cross the waiting period and undergo renal 
transplantation successfully, the immediate peri-operative period is a 
time of recovery and adjustment to new challenges. 
 In some patients, recovery will be uncomplicated and rapid, 
while in other patients, it may be with multiple complications and 
longer.  
Common postoperative complications such as  
• rejection episodes,  
• immunosuppressive medication side effects,  
• bleeding,  
• infection 
 may be perceived as negative set backs by the recipient, and can lead 
to frustration.  
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Managing patients during such period typically involves a                    
 combination of pain control,  
 education,  
 reassurance, and 
 monitoring for early psychiatric complications.  
 
Early Post-transplant Adaptation 
 
The immediate postoperative period places burdens on recipients 
and their families and caregivers due to the complex medical regimens. 
In addition to the medications, patients have to attend regular reviews 
and get laboratory tests done frequently, since discharge. 
 Even while at home, patients must follow diet restrictions, 
restrictions on some physical activity like lifting weight, driving etc.  
 
Transplant-Related Illness Behaviour 
 
Maladaptive illness behavior may interfere with adaptation to 
the transplantation psychologically.  
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Recipients may have two major types of such illness behavior.   
1)First, for patients who are struggling in their life for a long 
period with chronic disease, transplantation brings a transition from 
one state of illness to another, with family being expecting 
improvement in health status. But, some chronically ill patients got 
adapted to the sick role psychologically, with coping strategies that 
perpetuate their dependency on being sick. These patients may have 
difficulty on transitioning into a healthier state. They may feel that the 
clinical team is urging them to get fast recovery. Such patients may 
develop unexplained somatic complaints, like chronic pain, or have 
non-adherence to post transplant medications.  
2)The second type of maladaptive behavior is observed in 
patients who become acutely ill and undergo emergency renal 
transplantation. For such individuals, transplant may be an 
unwelcomed event. Awareness of their need for a donor organ would 
not have occurred until the peri-operative period. These patients may 
have difficulty accepting or denying their medical illness and post 
transplantation changes in life. They may attempt for faster recovery 
pushing them for that. They may have resent in receiving a transplant 
and may act out their anger or denial in episodes of non-adherence. 
 
 
17 
 
Long-Term Outcomes 
Most renal transplant recipients are in need of a multiyear period 
for them to achieve maximal functioning of the transplanted organ, 
which happens after a low level of post operative complications and 
infrequent episodes of organ rejection. Their near normal health status 
during this period contributes to improved emotional well-being.  
With time, however, other problems with the transplanted 
kidney may develop (e.g., chronic graft rejection) and patients are also 
at risk of complications of long-term immunosuppressive medication 
including diabetes, hypertension, and cancers. 
Overall transplantation extends life of ESRD patients and 
improves their health and quality of life compared to pre transplant 
dialysis period, but to the level of a normal healthy person. 
 
 
PSYCHIATRIC MORBIDITY IN ESRD PATIENTS: 
 
 Various studies have been conducted to assess the psychiatric 
morbidity in hemodialysis patients and also renal transplantation 
patients, few with comparison between them. Technological 
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advancement have produced longer survival rate after renal 
transplantation, which shifted the attention of the medical professionals 
towards the morbidities in the renal transplantation patients during the 
post operative period.  
 The patients under going maintenance hemodialysis for longer 
periods , which makes them more dependent on medical ailment and 
care givers are found to have more psychiatric morbidity like 
depression.  
Though it was expected that transplantation would provide some 
relief from this painful dialysis procedures and make them less 
dependent ,and free from like anxiety, depression etc., in reality it was 
not so. The existence of psychiatric disorders like depression and 
anxiety are severe even in the post transplant period.  
Several  etiologies have been described for the psychiatric 
morbidity in the renal transplant recipients like  
• physiological changes associated with organ 
insufficiency,complex procedures involved in the 
transplantation surgeries,  
• breach in the integrity of body structure and function ,  
• problem of getting a suitable organ donor,  
• fear of new organ being rejected after transplantation,  
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• financial issues ,  
• need for the dependence on life long immunosuppressant 
medications., and   
• accompanying psychological distress.  
 
PSYCHIATRY AND TREATMENT ADHERENCE: 
 
Drug adherence to immunosuppressant medication in the post 
transplantation period is now emerging as a big problem. There are 
studies which report that at least 20% of all renal transplant recipients 
are not adhering to their proper treatment schedule with medications 
and this non-adherence is a major cause of transplant rejection and 
premature transplant failure (Butler, 2002). Psychiatric intervention is 
needed in this area which causes great impact in management and graft 
survival. 
 Noncompliance due to medical causes such as poor tolerance is 
also important. It is calculated that about 25% of patients who are 
under treatment with immunosuppressive drugs are noncompliant and 
they may act as confounding factor in interpreting results of these 
studies negatively. Patient’s quality of life in the post transpslantation 
period is affected to a great extent by this poor drug compliance and it 
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also detrimental to society. (Jindel, Joseph, Morris, Santella, & Baines, 
2003) . 
Therefore anxiety and depression has to be assessed as a part of 
routine medical examination after every kidney transplantation. The 
high risk factors of noncompliance after kidney transplants so far 
studied are younger age group, female gender, unmarried persons, and 
non-Caucasians. Patients with a history of previous transplant long 
time before and those who are recipients of living donors are also 
found to be noncompliant.  
Psychosocial assessment must be included in the Pre-transplant 
screening procedure using one or more of the standardized instruments 
and those patients who are at high risk regarding noncompliance to 
drugs in posttransplant period has to be identified and given extra care 
and vigil. It is desirable to provide counseling to all  renal transplants 
recipients if  possible. 
 Focus shold be directed towards patients who are high risk of 
noncompliance ,which is a good cost-effective measure. This effort 
will definitely reduce the number of kidney transplants which are being 
lost due to noncompliance of drugs and it may even beneﬁt the society 
in economic aspect.(Matas et al., 2002) 
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DEPRESSION: 
 
 Depression ranks fourth among the disabling disease worldwide. 
It is the most common psychiatric morbidity among patients with end 
stage renal disease. Among end-stage renal disease (ESRD) patients, 
the frequency of depression was found to be  25% to 30% , specifically 
after the initiation of renal replacement therapy(Sezer, Mic, & Akman, 
2003).Psychosocial problems are related to the physical illness in these 
patients.  
Depression is somewhat difficult to diagnose in patients who are 
in terminal medical illness.  
The somatic symptoms of depression include  
• weight loss,  
• anorexia,  
• lack of energy,  
• sleep disturbance, and  
• retardation in psychomotor activity,  
may be presenting clinical feature of the physical illness.  
Whatever may be the cause the psychiatric diagnosis should be 
made applying the diagnostic criteria, but the psychiatrist must be 
aware of the possibility of overdiagnosis in such patients.  
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To prevent such mishappening, the cognitive symptom of 
depression has to be focused more during the assessment. The 
diagnosis of major depression is however supported by somatic 
symptoms if severity of those symptoms are more, disproportionate to 
the physical illness and can be correlated temporarily with the onset of 
symptoms of depression.  
Patients with physical illness with co-morbid depression have 
poorer levels of functioning and higher levels of morbidity and  
mortality compared with patients with physical illnesses without 
depression.(Wulsin, Vaillant, & Wells, 1999) 
  Among the renal disease patients; depression is more noticed 
among young transplant recipients and female patients. Younger 
recipients who has lost their previous full functioning capacity and 
who has to follow new limitations in their daily life that is 
unmodifiable in their future are at high risk of depression.  
The social support in chronically ill females is lower than that of 
males as observed in previous studies, making them more prone for 
depression. It is quiet obvious  factor that patients who have to wait for 
a longer time to receive a suitable cadaveric donor are at more risk for 
anxiety and depressive disorders, when compared to patients who are 
waiting for the transplant procedure with available live donor.  
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In married patients with satisfactory marital relationship , 
depression is less common since they  could share their psychological 
distress and get  good support .(Sezer et al., 2003) 
Some of the predictable factors for depression in renal transplant 
recipients are  those patients who are living alone, without a regular 
income, having a rejection episode, and those who dislike organ 
transplantation.(Tsunoda, Yamashita, Kojima, & Takahara, 2010) 
 
Paradoxical Depression: 
 
 Most of the renal transplant recipients will be having a better 
feeling after a renal transplantation as if they have got a new life and 
regained the lost renal function, so as to lead a normal life in their 
remaining future. Yet in few patients even after successful 
transplantation, depression develop . 
Paradoxical depression is depression occurring in recipient after 
a  successful renal transplantation without any rejection or other 
surgical and medical  postoperative complications.(Sugawara et al., 
2008) 
The term “paradoxical depression” is often applied to patients 
who have undergone successful transplantations with depressive 
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symptoms related to “burden relief” once the need for long-time 
dialysis has been eliminated. Fukunishi et al,deﬁned the diagnostic 
criteria for PPS, Paradoxical Psychiatric Syndrome ,reporting that PPS 
was frequently observed among adult recipients, especially those who 
underwent living-related transplantation.(Fukunishi et al., 2001) 
 
 The severity of depressive symptoms is found to be higher 
among those with lower educational status.(Karaminia et al., 2007) 
some other established risk factors are  
• being unmarried or unsatisfactory marital life, 
• poor family support,  
• comorbid medical conditions and  
• major stressful life. 
 
 Depression following renal transplantation is a serious condition 
since it not only leads to poorer quality of life, but also poor drug 
compliance which is equivalent to suicide in such patients as this 
causes graft rejection and life threatening consequences.  
There is increase in the number of renal transplantation and 
because of medical complexities; often depression is unlikely to be 
noticed. So to determine which patient requires specialized mental 
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health treatment, systematic screening and periodic reassessment has to 
be carried out in all the renal transplant recipients. 
 
Relationship Between Depression And Physical Illness: 
 
  The most common mode of the physical illness leading to the 
depressive illness is because of a direct biological mechanism, this is 
more so if the endocrine or central nervous systems are involved.  
The physical condition may also generate depression through a 
psychological reaction, especially if the condition is disabling or fatal. 
In general, two-thirds of depression patients in general hospital is 
because of some physical illness, or its management.  
Second, the physical problems may exacerbate due to depressive 
illness. Depression leads to other changes in health-related behaviours, 
like poor compliance with medications, diet, exercise and health care 
services utility.  
Third, the depressive and physical illnesses may have a common 
etiology, for example grief or stress may be the factor triggering the  
stroke and  the depression. 
Finally, the depressive illness may be unrelated to medical 
conditions, and may be just a co-incidental finding.  
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Depression also influence life style behaviours like physical 
activity in a negative way, which further adds on to the adverse 
consequences of low physical activity which is already present in the 
renal transplant therapy.  
Not only that, depressive symptoms like feelings of hopelessness 
and difficulty in concentration, memory disturbances will result in 
behaviours including forgetting pills or missing follow up 
appointments.(DiMatteo, Lepper, & Croghan, 2000) 
There is also an increased risk of suicide among depression 
patients with chronic physical illness and pain. Elderly people in this 
category may even deny their suicidal ideation but the risk of suicide is 
high in them. 
 
ANXIETY: 
 
 In transplant recipients, the factors influencing the severity of 
anxiety are 
a.  A history of graft rejection  
b. Age  < 35 years during  transplantation 
This can be explained from a psychodynamic point of view that 
people with a high level of anxiety undergoing transplantation are 
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probably more hypersensitive and tend to reject the transplant. That is, 
they worry more over trivial issues that a normal person would give 
no importance. Especially, this state of mind can cause excessive 
agony (for example, about the possibility of suffering a rejection, of 
suffering an infection), which harms the psychological and physical 
state of the patient in the long run. (Dew et al., 2001) 
Features of anxiety can result in poor adherence to medications, 
that is, as a result of  their own psychological state they tend to ignore  
healthy habits, which partly accounts for the occurrence of a poor 
quality of life of the transplant patients in the post discharge period of 
one year.(Dew et al., 2000)  
There are four  fundamental affected areas: (Mart, 2006) 
(1) Psychological area: 
These may manifest as anxiety symptoms or as depressive 
symptoms. 
• Features of anxiety may be evident as   
• “feel uptight,”  
• “feel tense or annoyed,”  
• “have a sense of fear, like something terrible might 
happen,”  
• “have their head full of worries,”  
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• “feel restless, like they cannot keep still,” and  
• “suddenly feel panic.”  
Features of depression may present as 
• “feel depressed,”  
• “do not feel happy,” and  
• “do not feel optimistic with respect to their future 
well-being”;  
(2) Social area:  
Their physical state and treatment “have a negative 
inﬂuence on their family life and social activities” 
(3) Physical area:  
• They usually suffer from  various gastrointestinal 
disturbances  (for example, “constipation” , diarrhea, 
upset stomach); 
• Cardiovascular symptoms like palpitations, chest pain 
etc 
• Respiratory symptoms like dysnoea, difficulty in 
breathing etc 
• Neurological symptoms like tremors ,syncope etc 
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• And various autonomic symptoms like sweating,, 
dry mouth etc 
 
 (4) Economic area:  
The symptoms of anxiety also have a negative 
impact on the persons financial status. 
 
QUALITY OF LIFE: 
 
 Quality of life is now becoming an vital concept in the 
assessment of various therapeutic aspects in patients with unremitting 
illness. The medical care has shifted its objective toward quality of life 
rather than survival rates and mortality rates as its key indicators of a 
therapeutic efficacy. In the ﬁeld of kidney transplantation the quality of 
life is now gaining importance as the patients are now having good 
surgical outcome and better longevity.  
The quality of life assessment, unlike other regular medical 
investigations requires  the patient  to assess his or her own physical 
and mental health by estimating their social situations and other 
economic aspects into consideration. However, the inconsistency of 
instruments and the absence of a clear definition poses various 
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practical difficulties in the assessment of the Quality of life. (Overbeck 
et al., 2005) .  
The Quality of Life assessment has been linked to clinical 
outcome in many studies. It has also been reported that the traditional 
philosophy and various religious beliefs existing in our country may 
also act as a coping mechanism and improve the quality of life in many 
domains in our patients. 
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AIM AND OBJECTIVES  
AIM 
The aim of this study is to study the prevalence of anxiety and 
depression, its clinical correlates and to assess the quality of life (QOL) 
among renal transplant recipients. 
 
OBJECTIVES: 
 
• To detect the psychiatric co-morbidity like anxiety, depression 
and it clinical correlates among renal transplant recipients. 
 
• To assess the quality of life in the post transplantation period of 
ESRD patients. 
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MATERIALS AND METHODS 
 
• Sample:*50 renal transplantation recipient patients (Random 
Sampling) attending the outpatient department, Department of 
Nephrology, Rajiv Gandhi Government General Hospital, 
Chennai. 
              *50 normal healthy subjects from general population. 
 
STUDY DESIGN 
 
       Case control study.  
       Cross sectional study. 
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MATERIALS USED 
A. Semi structured proforma to elicit socio economic and other 
information – past history, family history, personal history, 
premorbid personality details and clinical history. 
 
B. MMSE 
 
C. Hamilton Anxiety Rating Scale (HAM-A) 
 
D. Hamilton Depression Rating Scale (HAM-D) 
 
 
E. MINI Plus 
 
F. WHOQOL-BREF Questionnairre 
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CASES: 50 renal transplant recipient patients attending the out patient 
department, Department of Nephrology, Rajiv Gandhi Government 
General Hospital, Chennai. 
INCLUSION CRITERIA 
• Male and female patients attending the outpatient department, 
Department of Nephrology, Rajiv Gandhi Government General 
Hospital, Chennai. 
• Participants between 18-60 years of age 
• Willing to provide informed consent for the interview. 
EXCLUSION CRITERIA 
• Patients with known psychiatric illness before. 
• Patient is <18 and >60 years of age 
• Patients in a state of delirium 
• Un-cooperative patients 
• Refusal to provide informed consent. 
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CONTROLS: Age and gender matched 50 normal healthy subjects 
from general population. 
INCLUSION CRITERIA: 
• Participants between 18-60 years of age. 
• Normal healthy subjects from general population 
• Willing to provide informed consent for the interview. 
EXCLUSION CRITERIA 
• Patients with known psychiatric illness 
• Patients with chronic medical illness like End stage renal disease, 
decompensatory liver disease, Tuberclosis, Leprosy, Bronchial 
asthma, Stroke, Cancer, Ischemic Heart disease etc.  
• Patient is <18 and >60 years of age 
• Refusal to provide informed consent for assessment 
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HAM-D 
It is one of the most widely used and accepted scale to evaluate 
depression symptoms and its severity. It is designed to be administered 
by a trained health professional using a semi-structured interview. 
Though Hamilton has not provided any specific guidelines regarding 
the administration and scoring of the scale nor any standardized 
question for eliciting information from the patients, high inter-rater 
reliability has been observed using this scale. Several versions of 
HAM-D are available at present. The current version of HAM-D lists 
21 items of which one the first 17 are scored. The remaining provides 
additional clinical information. 
 Eight items are scored on a 5 point scale ranging from 0 – not 
present to 4 – severe. Nine items are scored on a 3 point scale from 0 to 
2. Sum of the first 17 items is calculated as the total score. 
• Normal – 0 to 7  
• Mild      - 8 to 13 
• Moderate – 14 to 18 
• Severe – 19 to 22 
• Very Severe – > = 23 
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HAM-A 
This is another scale which is used to evaluate anxiety symptoms 
in the patient.  
It has got 14 items the interviewer rates the individual on a five 
point scale for each of the 14 items. 
 Seven of the items specifically address psychic anxiety and the 
remaining seven items deal with somatic anxiety. 
 
The total score ranges from 0 to 56. 
 
• Normal – 0 to 13 
• Mild      – 14 to 17 
• Moderate – 18 to 24 
• Severe – 25 & above. 
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WHOQOL – BREF Questionnaire 
It is a generic health related questionnaire developed by the 
WHO QOL group - which helps to quantify the health related quality 
of life.  
It consists of 24 facets and it provides profile of scores on four 
dimensions of quality of life.  
 
The four domains are  
1) Physical Domain 
2) Psychological Domain 
3) Social Domain 
4) Environmental Domain 
 
After calculating the total of each domain the raw scores are converted 
in to transformed scores using the tables. The First transformation 
converts raw domain scores to a range of 4 to 20 and the second 
transformation converts it to a 0 to 100 scale. Higher scores are 
obtained with a better quality of life. 
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Mini-Mental State Examination (MMSE) 
 
It is a thirty point questionnaire by Folstein . 
 
          It is used to assess  
• cognition,  
• orientation to time and place, 
•  memory,  
• language use including comprehension/word 
repetition/reading/writing/drawing, attention, and 
arithmetic ability.  
 
 
Any score more than 27 out of 30 is considered normal. In the 
study, MMSE is used to screen the patients and assess if there is any 
cognitive impairment in them. 
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MINI – PLUS  
 It is Mini International Neuropsychiatric Interview. It was 
designed to diagnose the axis one psychiatric disorders in DSM IV and 
ICD 10. It is a structured interview which is brief used by clinicians 
after giving instructions and training the patients in a short session. It 
has got good validity and reliability scores.  
 It is important in part of the clinician to make sure that the 
patient should give importance to each dimension of the questions in 
the interview. The symptoms due to organicity or substance use are 
given space to be coded separately which is in contrast to MINI. The 
general format is divided into modules and identified by letters that are 
corresponding to a particular category.  
The assessment tool is divided into modules each representing a 
major psychiatric diagnosis and the main questions eliciting responses 
to meet the diagnostic criteria of a disorder are given in gray boxes. 
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TYPE OF STUDY 
Case control study 
  
 
PERIOD OF STUDY 
May 2012 to November 2012 
 
 
PLACE  
Rajiv Gandhi Government General Hospital,  
Chennai. 
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METHODOLOGY: 
The study was conducted between May 2012 and November 
2012. 50 transplant recipients and 50 control subjects who were 
matched for age and gender participated. All participants were living 
independently in the community. There was no difference between the 
two groups in age and gender proportion and on the scores of  
MMSE. 
In view of the high incidence of cerebro-vascular disease in 
renal transplant recipients cognition was assessed to exclude any 
deficit. All Participants were then screened for absence of any 
psychiatric disease. It was ensured that the controls were healthy and 
were not suffering from renal disease. The presence study also 
deliberately excluded those transplant recipients who had undergone 
transplant procedure less than or equal to six months. This is to avoid 
the risk of anxiety connected with the major surgical procedure and 
possible acute rejection. 
 
In the present study patients attending the review OP of 
nephrology department were studied. In the post operative period after 
discharge patients were supposed to attend the nephrology department 
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every 15 days for clinical and biochemical evaluation and also getting 
their regular medication.  
Surprisingly almost all the patients who were studied were 
observed with good drug compliance as evaluated through the self 
reported questionnaire and corroborated with their review records 
which were properly maintained by the Department, even though the 
serum creatinine value was not found under control for majority of the 
transplant recipients.  
 
Demographic information like  
1. age,  
2. sex,  
3. education, 
4. occupation,  
5. income,  
6. maritial status ,  
7. family type,  
8. area of residence  
were collected from the patients.  
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This study had included patients with age group 18 to 60 years, 
however the 50 taken were classified into five age groups such as  
1) 18 to 24, 
2) 25 to 35, 
3) 36 to 45, 
4) 46 to 55  
5) more than 55  
since it would easier to get matched with the respective groups among 
controls and exact age matching was not possible practically.  
The education status was recorded in five groups  
1. uneducated,  
2. schooling & SSC, 
3. HSC,  
4. Graduate  
5. Post – graduate. 
 The occupation statuses were divided into four groups as 
unemployed, unskilled, skilled and professional.  
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The income was recorded in four groups, according to 
Kuppusamy classification, It is recently revised to seven groups  
such as  
I. less than 1520,  
II. 1521 to 4555,  
III. 4556 to 7593,  
IV. 7594 to 11361,  
V. 11362 to 15187 ,  
VI. 15188 to 30374 and 
VII. more than 30374. 
 
The Medical history details collected to correlate clinical 
parameters with depression and anxiety were as follows  
 
1) Cumulative end stage renal disease (ESRD) , it is the time period 
since the initiation of the first treatment from ESRD in months 
hence recorded 
 
2) The no of co morbid condition & it is recorded in 3 groups such 
as nil,  
1 or 2 conditions, and 
more than 3 conditions.  
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3) The time on analysis before the transplant is calculated in 
months was obtained from the patients. 
 
4) Transplant vintage period that is  the time elapsed since the time 
of transplant surgery ,was recorded 
 
 
5) Type of donor whether 
 living or  
dead 
 
6) The number of rejection episodes classified in to three groups ie) 
no rejection group/ 
one or two rejection group/ 
more than three rejection group 
 
7) Complication of post operative medication like steroids and 
immuno suppressions if any was recorded in two groups ie) 
 nil or  
present 
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8) The drug compliance was registered as either  
good or 
 poor  
from self reported corroborated with records maintained by the 
department 
 
9) The history of inter-current infection is classified either as 
 nil or  
present. 
 
     10)  The last serum creatinine value was collected from the lab 
records maintained. 
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The study was approved by the ethical committee of Madras Medical 
College in the month of Aug 2012. 
 
Before enrolling the patients in the study, detailed verbal and written 
information was given to the patient regarding the aim and protocol of 
the study and a signed inform consent was obtained. 
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Statistical Analysis 
The statistical analysis was carried out using SPSS-20 soft ware. 
The collected Datas were summarized using proportion, number, 
percentage,mean , standard deviation, whichever was found to be 
Appropriate for the particular data .  
 Independent student T test was applied to compare continuous 
variable and chi square test was applied to compare categorical 
variables. In all statistics analysis, 2-sided tests were used for the 
appropriate datas and results were considered statistically signiﬁcant if 
P value is less than 0.05 
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RESULTS 
The results of the socio demographic profile including age, sex, 
education, occupation, income, marital status, religion, area, family 
type was tabulated in Table 1 and Table 2. Chi square test was applied 
to compare the proportion between cases and controls. 
As taken for study both the groups are matched for age and 
gender, but there was significant difference between the cases and 
controls regarding education and occupation. 7% of the studied cases 
and 15% of the controls were uneducated. In the studied cases 16% 
were Post Graduates where as only the 2% of the controls were post 
graduates. And there was not much difference in other categories of 
education among cases and controls. Regarding occupation 40% of the 
cases are unemployed where as only 20% were unemployed. With 
respect to area of residence, while the majority of controls were from 
urban area, the cases were equally distributed that is 50% from urban 
and 50% from rural areas. The cases living in joint family set up is 
30% which is high compared to 6% in controls. There was no 
significant difference in other socio demographic parameters. 
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Chi-Square test to compare the proportions between Cases and 
Controls 
 
Table No:1 
 
Variables 
Group 
Total 
P-Value Cases Controls 
N % N % N % 
Age 
18 - 24 10 20.0 10 20.0 20 20.0 
- 
25 - 35 19 38.0 19 38.0 38 38.0 
36 - 45 15 30.0 15 30.0 30 30.0 
46 - 55 4 8.0 4 8.0 8 8.0 
>55 2 4.0 2 4.0 4 4.0 
Sex 
Male 39 78.0 39 78.0 78 78.0 
 
Female 11 22.0 11 22.0 22 22.0 
Education 
Uneducated 7 14.0 15 30.0 22 22.0 
0.035 
School/SSL
C 15 30.0 20 40.0 35 35.0 
HSC 15 30.0 10 20.0 25 25.0 
Graduate 5 10.0 4 8.0 9 9.0 
Postgraduate 8 16.0 1 2.0 9 9.0 
Occupation 
Unemployed 20 40.0 10 20.0 30 30.0 
0.004 
Un-skilled 15 30.0 29 58.0 44 44.0 
Skilled 15 30.0 8 16.0 23 23.0 
Professional 0 .0 3 6.0 3 3.0 
Total 50 100.0 50 100.0 100 100.0  
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Table No - 2 
Variables 
Group 
Total 
P-Value Cases Controls 
N % N % N % 
Income 
< 1520 13 26.0 10 20.0 23 23.0 
0.894 
1521 - 4555 18 36.0 19 38.0 37 37.0 
4556 - 7593 9 18.0 11 22.0 20 20.0 
7594 - 
11361 4 8.0 3 6.0 7 7.0 
11362 - 
15187 1 2.0 5 10.0 6 6.0 
15188 - 
30574 4 8.0 1 2.0 5 5.0 
> 30574 1 2.0 1 2.0 2 2.0 
Marital 
status 
Unmarried 13 26.0 19 38.0 32 32.0 
0.284 Married 36 72.0 31 62.0 67 67.0 
Divorced 1 2.0 0 .0 1 1.0 
Religion 
Hindu 41 82.0 40 80.0 81 81.0 
0.866 Muslim 4 8.0 6 12.0 10 10.0 
Christian 5 10.0 4 8.0 9 9.0 
Area 
Urban 25 50.0 39 78.0 64 64.0 
0.004 
Rural 25 50.0 11 22.0 36 36.0 
Family 
type 
Nuclear 35 70.0 47 94.0 82 82.0 
0.002 
Joint 15 30.0 3 6.0 18 18.0 
Total 50 100.0 50 100.0 100 100.0  
 
 
 
 
 
 
53 
 
 
 
Chart No - 1 
 
 
 
 
This is a pie chart depicting the percentage of age group among the 
renal transplant recipients.Age group from 18 to 60 years were 
included in the study. Among cases majority of them were in the 
younger age group. Of that 38% were in the age group of 25 to 35 
years. 
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Chart No - 2 
 
 
 
 
This is a pie chart depicting the percentage distribution of gender 
among the transplant recipient group. Nearly three fourth of  patients 
were males in the present study. 
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Independent samples T-Test to compare the mean values between 
Cases and Controls 
 
 
Table no 3 
 
Variables Group N Mean Std. Deviation P-Value 
MMSE 
Cases 50 28.600 0.857 
0.714 Control
s 50 28.660 0.772 
HAM D 
Cases 50 10.040 4.729 
<0.001 Control
s 50 6.960 2.990 
HAM A 
Cases 50 9.260 3.367 
0.004 Control
s 50 7.540 2.451 
TD 2 
Cases 50 58.080 13.083 
0.555 Control
s 50 59.480 10.432 
TD 3 
Cases 50 54.900 12.006 
0.224 Control
s 50 57.680 10.668 
TD 4 
Cases 50 51.320 17.356 
0.017 Control
s 50 59.320 15.516 
TD 1 
Cases 50 54.900 14.558 
0.426 Control
s 50 57.040 12.066 
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On applying independent sample T Test to compare the mean 
values between the cases and controls there was a significant 
difference in HAM-D score (p <0.001)  and HAM-A score ( p =0.004) 
which found in Table No - 3.  Also there is significant difference in the 
p value in the environmental domain of the quality of life when 
compared between cases and controls 
 
Chart No - 3 
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The above chart clearly depicts the significant difference in the 
mean values of HAM – D scores between the renal transplant 
recipients and normal healthy subjects. 
Chart No - 4 
 
 
This chart visualizes the significant difference in mean values of  
HAM-A Scores between the transplant patients and the control 
group,    which is less than that of depressive scores. 
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Chart No - 5 
 
 
This chart clearly depicts the significant difference in the mean values 
of cases and controls in the environmental domain of quality of life(TD 
4), as assessed by WHO QOL –BREF Questionnaire. 
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Statistics for cases alone 
 
Mean values 
 
Table No: - 4 
 
Variables N Mean Std. Deviation 
Cumulative ESRD 50 51.200 29.609 
Time on dialysis before transplant 
(months) 50 13.020 20.462 
Transplant vintage 50 26.520 19.732 
Creatinine 50 1.402 0.504 
 
 
The mean and standard deviation of some of the clinical 
correlates studied like cumulative ESRD and time on dialysis before 
transplant, transplant vintage period were tabulated in Table 4.  The 
mean value for cumulative ESRD is 51 months and on an average 13 
months nearly one year was spent on dialysis before transplantation. 
The mean value for the transplant vintage period is 26 months which is 
nearly two years. The mean creatinine value was found to be 1.4.  
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Table No: - 5 
Variables 
Frequency 
N % 
Co morbid conditions 
Nil 45 90.0 
1 or 2 5 10.0 
Type of donor 
Living 39 78.0 
Cadaver 11 22.0 
No. of rejection episodes 
Nil 40 80.0 
1 or 2 10 20.0 
Complication of post op 
medications 
Absent 22 44.0 
Present 28 56.0 
Drug compliance 
Good 49 98.0 
Poor 1 2.0 
History of inter current infection 
Absent 34 68.0 
Present 16 32.0 
Total 50 100.0 
 
In Table - 5 the study showed in 90% of patients there was no 
pro morbid conditions and in 80% of transplant recipients there was 
not history of any rejection episode. In more than 3/4th of the transplant 
procedures were living donors. It was also noted that though 56% of 
patients had complications due to post operative medications, 
surprisingly their drug compliance was very good as 98%. There was 
history of inter current infection in 32% of the renal transplant 
recipients. 
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Independent samples t-test to compare the mean values between 
comorbid conditions  
 
Table No – 6 
 
 
Clinical 
features 
Co 
morbid 
conditions 
N Mean Std. Deviation P-Value 
HAM D 
Nil 45 9.33 4.333 
0.001 
1 or 2 5 16.40 3.362 
HAM A 
Nil 45 9.33 3.490 
0.649 
1 or 2 5 8.60 2.074 
TD 2 
Nil 45 59.82 11.886 
0.004 
1 or 2 5 42.40 14.188 
TD 3 Nil 45 56.40 11.151 0.007 
 1 or 2 5 41.40 12.033  
TD 4 Nil 45 52.58 16.858 0.125 
 1 or 2 5 40.00 19.647  
TD 1 Nil 45 56.27 13.885 0.045 
 1 or 2 5 42.60 16.288  
 
 
 
In Table 6 – The independent sample t test was used to compare 
the mean values between the co morbid conditions. The P value (p is 
equal to 0.001) was significant in HAM-D and physical psychological 
& social domain of quality of life.  
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Chart No – 6 
 
 
 
 
 
 
 
This bar chart clearly shows the significant difference in mean values  
 
of HAM –D scores with  presence of comorbid conditions. 
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Chart No - 7 
 
 
 
 
 
This chart depicts the difference in mean values of psychological  
 
domain of quality of life with presence of  comorbid conditions  
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Chart No – 8 
 
 
 
 
 
This chart depicts the difference in mean values of environmental 
 
domain of quality of life with presence of  comorbid conditions  
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Chart No - 9 
 
 
 
 
 
This chart depicts the difference in mean values of physical 
 
domain of quality of life with presence of  comorbid conditions  
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Independent samples t-test to compare the mean values between 
types of donor  
 
Table No 7 
 
 
Clinical 
features 
Type of 
donor N Mean Std. Deviation P-Value 
HAM D 
Living 39 10.13 4.780 
0.807 
Cadaver 11 9.73 4.756 
HAM A 
Living 39 9.28 3.494 
0.932 
Cadaver 11 9.18 3.027 
TD 2 
Living 39 57.74 13.172 
0.736 
Cadaver 11 59.27 13.320 
TD 3 
Living 39 55.59 12.283 
0.450 
Cadaver 11 52.45 11.157 
TD 4 
Living 39 53.03 17.719 
0.194 
Cadaver 11 45.27 15.212 
TD 1 
Living 39 54.92 14.631 
0.983 
Cadaver 11 54.82 14.999 
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Chart No - 10 
 
 
 
 
 
 
There was no significant finding on applying independent sample T 
test on comparing the mean values between type of donor, either living 
or cadaver among cases. 
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Independent samples t-test to compare the mean values between 
No. of rejection episodes 
 
Table No 8 
 
 
Clinical 
features 
No. of 
rejection 
episodes 
N Mean 
Std. 
Deviatio
n 
P-Values 
HAM D 
Nil 40 9.55 4.408 
0.145 
1 or 2 10 12.00 5.676 
HAM A 
Nil 40 9.40 3.463 
0.562 
1 or 2 10 8.70 3.057 
TD 2 
Nil 40 58.65 12.963 
0.543 
1 or 2 10 55.80 14.022 
TD 3 
Nil 40 56.25 11.624 
0.113 
1 or 2 10 49.50 12.599 
TD 4 
Nil 40 52.15 17.606 
0.504 
1 or 2 10 48.00 16.780 
TD 1 
Nil 40 54.98 14.783 
0.943 
1 or 2 10 54.60 14.377 
 
 
 
 
There was no significant finding on applying independent sample T 
test on comparing the mean values between number of rejection 
episodes among cases. 
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Chart No - 11 
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Independent samples t-test to compare the mean values between 
Complication of post op medications 
 
Table No 9 
 
 
 
Complicati
on of post 
op 
medication
s 
N Mean Std. Deviation P-Value 
HAM D 
Absent 22 10.00 4.504 
0.958 
Present 28 10.07 4.981 
HAM A 
Absent 22 9.18 3.290 
0.886 
Present 28 9.32 3.486 
TD 2 
Absent 22 60.18 11.245 
0.319 
Present 28 56.43 14.349 
TD 3 
Absent 22 55.55 11.521 
0.740 
Present 28 54.39 12.559 
TD 4 
Absent 22 52.50 17.281 
0.675 
Present 28 50.39 17.675 
TD 1 
Absent 22 56.50 13.244 
0.497 
Present 28 53.64 15.635 
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Chart No - 12 
 
 
 
 There was no significant finding on applying independent 
sample T test on comparing the mean values between complications of 
post operative medications among cases. 
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Independent samples t-test to compare the mean values between 
History of intercurrent infection 
 
Table No 11 
 
Clinical 
Features 
History of 
inter 
current 
infection 
N Mean Std. Deviation P-Values 
HAM D 
Absent 34 9.65 4.618 
0.397 
Present 16 10.88 5.005 
HAM A 
Absent 34 9.00 3.542 
0.432 
Present 16 9.81 2.994 
TD 2 
Absent 34 59.06 12.615 
0.446 
Present 16 56.00 14.222 
TD 3 
Absent 34 55.24 10.589 
0.803 
Present 16 54.19 14.945 
TD 4 
Absent 34 53.44 15.607 
0.211 
Present 16 46.81 20.403 
TD 1 
Absent 34 56.03 13.449 
0.430 
Present 16 52.50 16.892 
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Chart No - 13 
 
 
 
 
There was no significant finding on applying independent sample T 
test on comparing the mean values between histories of inter-current 
infection among cases. 
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DISCUSSION 
 
The present study used HAM-D, HAM-A and WHOBREF 
questionnaire to evaluate depression, anxiety and the quality of life of 
the subjects respectively.  
Various studies have been conducted to compare the psychiatric 
morbidity like depression and anxiety between the renal transplant 
recipients and patients on maintenance hemo-dialysis. The results of 
those studies were controversial.  
One such study conducted in 2007 concluded that depression 
continued to remain in the post transplantation period as severe as in 
the pre transplantation period and our study had also derived results in 
line with the same.  
Another similar case control study conducted in 2010 which 
compared anxiety, depression and emotional profile in renal transplant 
recipients with healthy subjects found no significant difference 
between the cases and controls in depression and anxiety but noted 
difference in their affective profile.  
The present study differed from that of the previous studies and a 
significant difference was noted both in depression and anxiety 
between the transplant recipients and healthy subjects. Though 
transplantation offers the patients a chance to prolong their expectancy 
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of life and its quality, it does it at the expense of new worries such as 
fear of graft rejection, necessity to continue life long 
immunosuppressant medications, permanent life style changes etc.  
 When the socio demographic factors were analyzed, most of the 
patients who underwent renal transplantation were in the younger age, 
which was similar to the other such study findings. It was also studied 
previously that young age transplant recipients showed more anxiety 
levels.  
Though it was not correlated so in the current study, if more 
number of cases were included, it might be possible to assess further 
and find the cause of anxiety in such young renal recipients. Nearly 
half of the cases (40 %) were unemployed which is twice that of those 
in controls which can be viewed as a result of their physical condition 
with psychiatric co morbidity that interferes with their productivity and 
dependence that made them dependent on their relatives and family. 
This can be evidenced from the observation of more number of 
recipients living in joint family compared to controls though there 
might be some other reasons for the same observation.  
In the present study three fourth of patients were males. It 
replicates the same as in other studies conducted in renal transplant 
recipients. Some of the previous studies said that female gender was a 
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risk factor for depression among the transplant group, due to poor 
social support for females and the current study has to be conducted in 
more elaborative way to get such corroborative finding. 
We noted that nearly half of the recipients had developed some 
complications due to immunosuppressant drugs including weight gain, 
cataract, insulin resistance, skin eruptions etc they were continuing 
drugs regularly and the reason being fear of rejection episodes in most 
of them.  
A meta analysis showed that there was strong correlation between 
depression and drug adherence (DiMatteo et al., 2000) .But we have 
observed that there was not much disturbances in drug compliance in 
those depressed recipients. 
 In our study we found that the prevalence of anxiety in the 
patients were significant as evidenced by significant P value in the 
comparison between cases and controls, we noted good drug adherence 
in our study population in contrast to the fact from a study that reported 
that in addition to depression, anxiety of post transplant patients has 
influence on the drug compliance (Mart, 2006).  
 A study conducted in 2008 assessing the quality of life in 
patients undergoing hemodialysis using the same WHOQOL-BREF 
questionnaire which we have used in our study have found low scores 
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in the physical, psychological and social domains compared to normal 
healthy population and no changes in the environmental domain of the 
QOL. Our current study depicted a significant impairment in the 
environmental domain and without much significant changes in the 
physical, psychological and social domain in post transplant patients 
which may be due to improvement in the psychological and physical 
well being of the recipients secondary to a positive attitude of our 
patients on their life expectancies following transplantation. 
 These findings are consistent with the earlier published reports 
that showed those patients who underwent transplantation surgery had 
a positive view on their life, with a belief that transplantation would 
decrease their dependency and relieve them from frequent, invasive, 
costly dialysis procedures(Sathvik, Parthasarathi, Narahari, & Gurudev, 
2008). Also India being a country with high values on family and 
social support compared to the western population that could have led 
to a good positive impact on the perceived health status of patients 
with improved psychological well being as a result of care and concern 
of the family towards the patient. 
The environmental domain of QOL is mainly determined by the 
factors like financial status, employment, work place, accessibility to 
health care system, security, participation in leisurely activities. In our 
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study we found a significant impairment in the environmental domain 
of the QOL which might be secondary to disturbances in their 
employment status, ability to sustain the job following a chronic 
disease, accessibility to the hospital and decreased opportunities for 
them to participate in recreational activities. 
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LIMITATIONS: 
 
 
Though we conducted the study with our utmost efficiency the 
results have to be viewed with some limitations.  
The main limitation in the study is that relatively small numbers of 
subjects were included in the study. 
Though there was significant difference in the depressive score 
when correlated with the presence of co morbid conditions, only a very 
small percentage of study sample had co morbid medical illnesses. It 
goes along with the previous studies which have reported that the 
presence of co morbid conditions increases the depression scores.  
This study is a cross sectional case control study. A prospective 
study will be more fruitful while analyzing various clinical correlates 
with depression.  
Also if the number of the sample is more, data could have be 
analyzed in more detail and significance could have been obtained in 
the previous studied factors like positive correlation between 
depression and drug adherence, depression with co-morbid conditions, 
depression with time spent on dialysis before transplantation i.e, 
waiting period .   
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Another limiting factor is that the study has been conducted in a 
single hospital. So the results observed in this study could not be 
representative of general population and it could not be generalized 
without further considerations. 
 Also due to practical difficulties faced during the study, 
randomization could not be done, which becomes another limitation in 
validating the results. 
There is also a possibility of bias in selection of patients which 
could be one of the reasons for getting very good drug compliance 
among the recipients, since only the patients attending the review out 
patient department of nephrology were studied. If those who had been 
hospitalized in the post transplantation period either for rejection 
episodes or acute illness were also included, the values could be lower 
than this. The reasons for non-compliance in them, if any could have 
been studied in detail and correlated with depression scores. 
 
One another limitation factor is that pre transplantation 
psychological assessment was not done for the recipients in our study, 
which is a predictable factor for the occurrence of psychiatric 
morbidity following stressful surgical transplant procedure.  
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Since it is a well studied factor in several studies that renal 
transplant recipients have higher prevalence of depression and anxiety 
than general population, and an objective assessment was done with 
the scales for depression and anxiety , there is a possibility of 
expectation bias in this study. 
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FUTURE DIRECTIONS: 
 The present study is only a cross sectional study. The patients 
have to be analyzed prospectively for correlating various clinical 
parameters with the mental status of the patient. Since in the current 
scenario , many patients undergo renal transplantation at a very 
younger age, treating depression and other psychiatric co-morbidity in 
their post transplantation period, not only improves the drug adherence , 
thereby graft survival, but also the quality of their remaining part of 
life, their functioning capacity, employment status, family support and 
even marital functions. 
 Since it has been reported in some studies that the tedious renal 
transplant procedure leads on to depression even in their spouses 
because of care giver burden, which affects their entire family life, 
spouse should be educated regarding such issues in the pre 
transplantation period and to prepare them mentally to face such 
challenges. 
 The treating clinicians should be extra cautious both in 
diagnosing and in treating psychiatric morbidity at the right time for an 
adequate period . Sometimes it can even be life saving since cases of 
suicide have been reported in the post transplantation period. It is a real 
tragedy that for a transplant procedure not only high cost is spent but 
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also the live donor faces extra risk. Either pharmacological measures 
such as antidepressant medications or pharmacological measures like 
psychotherapy, cognitive behaviour therapy can be tried in eligible 
candidates. In future, research has to be conducted in such areas to find 
out if non pharmacological measures are equally efficacious in such 
patients, to avoid drug interactions in them. 
 Studies have to be carried out in further clarifying the 
relationship between certain psychosocial factors and psychiatric co-
morbidity, to point out the patients who are vulnerable to develop 
psychiatric illness in the post operative period so that additional 
assessment  can be done, and symptoms can be treated earlier.  
 Not only pre-transplant psychiatric assessment of the candidates, 
but also screening and periodic reassessment of the recipients 
systematically using diagnostic interviews or validated assessment 
tools is of vital importance. Also measures have to be taken for proper 
referral of the patient to specialist care, consultation-laison psychiatrist 
for appropriate management and follow up. 
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CONCLUSION:  
 This study was conducted in a tertiary care centre assessing the 
patients after 6 months of post renal transplant for psychiatric  
co-morbidity like anxiety, depression and also quality of life in the 
patients with strict methodology .Even though the study has its own 
limitation we could conclude from the study that patients after 
successful renal transplant inspite of devoid of life threatening 
complications have significant amount of depression and anxiety 
features and impairment in environmental domain of quality of life . 
This finding has to be seriously considered  in future to regularly 
follow up these patients with periodic assessment for psychological co-
morbidity and consider appropriate intervention through effective 
consultation liaison process as this would help the patients who came 
out of a terminal end stage illness.  
 
 
 
 
 
 
 
 
85 
BIBLIOGRAPHY 
 
1. Alavi, N. M., Aliakbarzadeh, Z., & Sharifi, K. (2009). Depression, anxiety, 
activities of daily living, and quality of life scores in patients undergoing 
renal replacement therapies. Transplantation Proceedings, 41(9), 3693–3696. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19917369 
2. Butler, J. (2002). Psychiatry and treatment adherence in the renal unit. 
Advances in Psychiatric Treatment, 8(2), 159–159. doi:10.1192/apt.8.2.159 
3. Dew, M. A., Kormos, R. L., DiMartini, A. F., Switzer, G. E., Schulberg, H. 
C., Roth, L. H., & Griffith, B. P. (2001). Prevalence and risk of depression 
and anxiety-related disorders during the first three years after heart 
transplantation. Psychosomatics, 42(4), 300–313. Retrieved from 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&
dopt=Citation&list_uids=11496019 
4. Dew, M. A., Switzer, G. E., DiMartini, A. F., Matukaitis, J., Fitzgerald, M. 
G., & Kormos, R. L. (2000). Psychosocial assessments and outcomes in 
organ transplantation. Progress In Transplantation Aliso Viejo Calif, 10(4), 
239–259; quiz 260–261. 
5. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a 
risk factor for noncompliance with medical treatment: meta-analysis of the 
effects of anxiety and depression on patient adherence. Archives of Internal 
Medicine, 160(14), 2101–2107. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/10904452 
6. Fukunishi, I., Sugawara, Y., Takayama, T., Makuuchi, M., Kawarasaki, H., 
& Surman, O. S. (2001). Psychiatric disorders before and after living-related 
transplantation. Psychosomatics, 42(4), 337–343. 
 
86 
7. Jindel, R. M., Joseph, J. T., Morris, M. C., Santella, R. N., & Baines, L. S. 
(2003). Noncompliance After Kidney Transplantation : A Systematic 
Review, 2872, 2868–2872. doi:10.1016/j.transproceed.2003.10.052 
8. Karaminia, R., Tavallaii, S. A., Lankarani, M. M., Mirzaie, H. H., Einollahi, 
B., & Firoozan, A. (2007). Anxiety and Depression : A Comparison 
Between Renal Transplant Recipients and Hemodialysis Patients, 1084, 
1082–1084. doi:10.1016/j.transproceed.2007.03.088 
9. Kemper, M. J., Spartà, G., Laube, G. F., Miozzari, M., & Neuhaus, T. J. 
(2003). Neuropsychologic side-effects of tacrolimus in pediatric renal 
transplantation. Clinical Transplantation, 17(2), 130–134. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12709079 
10. Kornfeld, D. S. (2002). Consultation-liaison psychiatry: contributions to 
medical practice. The American journal of psychiatry, 159(12), 1964–72. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12450941 
11. Lipowski, Z. J. (1986). Consultation-liaison psychiatry: the first half century. 
General Hospital Psychiatry, 8(5), 305–315. 
12. Mart, A. (2006). The Influence of Posttransplant Anxiety on the Long-Term, 
2408, 2406–2408. doi:10.1016/j.transproceed.2006.08.069 
13. Matas, A. J., Humar, A., Gillingham, K. J., Payne, W. D., Gruessner, R. W. 
G., Kandaswamy, R., Dunn, D. L., et al. (2002). Five preventable causes of 
kidney graft loss in the 1990s: a single-center analysis. Kidney International, 
62(2), 704–714. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12110036 
14. Nogueira, E., Camara, N. O. S., Da Luz Fernandez, M., Salvador, F., Costa, F. 
P. M., Cenedeze, M. A., Ozaki, K. S., et al. (2010). Evolution of renal 
transplantation in India over the last four decades. NDT Plus, 3(2), iii538. 
doi:10.1093/ndtplus/sfp178 
 
87 
15. Noohi, S., Khaghani-Zadeh, M., Javadipour, M., Assari, S., Najafi, M., 
Ebrahiminia, M., & Pourfarziani, V. (2007). Anxiety and depression are 
correlated with higher morbidity after kidney transplantation. Transplantation 
Proceedings, 39(4), 1074–1078. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/17524895 
16. Overbeck, I., Bartels, M., Decker, O., Harms, J., Hauss, J., & Fangmann, J. 
(2005). Changes in Quality of Life After Renal Transplantation, 1621, 1618–
1621. doi:10.1016/j.transproceed.2004.09.019 
17. Parkar, S. R., & Sawant, N. S. (2010). Liaison psychiatry and Indian research. 
Indian journal of psychiatry, 52(Suppl 1), S386–8. doi:10.4103/0019-
5545.69274 
18. Pascazio, L., Nardone, I. B., Clarici, A., Enzmann, G., Grignetti, M., Panzetta, 
G. O., & Vecchiet, C. (2010). Anxiety , Depression and Emotional Profile in 
Renal Transplant Recipients and Healthy Subjects : A Comparative Study. 
TPS, 42(9), 3586–3590. doi:10.1016/j.transproceed.2010.08.056 
19. Sathvik, B. S., Parthasarathi, G., Narahari, M. G., & Gurudev, K. C. (2008). 
An assessment of the quality of life in hemodialysis patients using the 
WHOQOL-BREF questionnaire. Indian journal of nephrology, 18(4), 141–9. 
doi:10.4103/0971-4065.45288 
20. Sezer, S., Mic, H., & Akman, B. (2003). Depression Levels Before and After 
Renal Transplantation, (45), 111–113. 
doi:10.1016/j.transproceed.2003.11.021 
21. Shuto, H., Kataoka, Y., Kanaya, A., Matsunaga, K., Sueyasu, M., & Oishi, R. 
(1998). Enhancement of serotonergic neural activity contributes to 
cyclosporine-induced tremors in mice. European Journal of Pharmacology, 
341(1), 33–37. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9489853 
 
88 
22. Sugawara, H., Nishimura, K., Kobayashi, S., Ishida, H., Tanabe, K., & 
Ishigooka, J. (2008). Paradoxical Depression in Renal Transplant Recipients. 
TPS, 40(10), 3448–3450. doi:10.1016/j.transproceed.2008.06.112 
23. Tsunoda, T., Yamashita, R., Kojima, Y., & Takahara, S. (2010). Risk factors 
for depression after kidney transplantation. Transplantation proceedings, 
42(5), 1679–81. doi:10.1016/j.transproceed.2009.12.073 
24. Vettath, R. E., Reddy, Y. N. V, Dutta, S., Singh, Z., Mathew, M., & Abraham, 
G. (2012). A multicenter cross-sectional study of mental and physical health 
depression in MHD patients. Indian journal of nephrology, 22(4), 251–6. 
doi:10.4103/0971-4065.101243 
25. Wulsin, L. R., Vaillant, G. E., & Wells, V. E. (1999). A systematic review of 
the mortality of depression. Psychosomatic Medicine, 61(1), 6–17. Retrieved 
from http://www.ncbi.nlm.nih.gov/pubmed/17888809 
26. Alavi, N. M., Aliakbarzadeh, Z., & Sharifi, K. (2009). Depression, anxiety, 
activities of daily living, and quality of life scores in patients undergoing 
renal replacement therapies. Transplantation Proceedings, 41(9), 3693–3696. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19917369 
27. Butler, J. (2002). Psychiatry and treatment adherence in the renal unit. 
Advances in Psychiatric Treatment, 8(2), 159–159. doi:10.1192/apt.8.2.159 
28. Dew, M. A., Kormos, R. L., DiMartini, A. F., Switzer, G. E., Schulberg, H. 
C., Roth, L. H., & Griffith, B. P. (2001). Prevalence and risk of depression 
and anxiety-related disorders during the first three years after heart 
transplantation. Psychosomatics, 42(4), 300–313. Retrieved from 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&
dopt=Citation&list_uids=11496019 
29. Dew, M. A., Switzer, G. E., DiMartini, A. F., Matukaitis, J., Fitzgerald, M. 
G., & Kormos, R. L. (2000). Psychosocial assessments and outcomes in 
organ transplantation. Progress In Transplantation Aliso Viejo Calif, 10(4), 
239–259; quiz 260–261. 
 
89 
30. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a 
risk factor for noncompliance with medical treatment: meta-analysis of the 
effects of anxiety and depression on patient adherence. Archives of Internal 
Medicine, 160(14), 2101–2107. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/10904452 
31. Fukunishi, I., Sugawara, Y., Takayama, T., Makuuchi, M., Kawarasaki, H., 
& Surman, O. S. (2001). Psychiatric disorders before and after living-related 
transplantation. Psychosomatics, 42(4), 337–343. 
32. Jindel, R. M., Joseph, J. T., Morris, M. C., Santella, R. N., & Baines, L. S. 
(2003). Noncompliance After Kidney Transplantation : A Systematic 
Review, 2872, 2868–2872. doi:10.1016/j.transproceed.2003.10.052 
33. Karaminia, R., Tavallaii, S. A., Lankarani, M. M., Mirzaie, H. H., Einollahi, 
B., & Firoozan, A. (2007). Anxiety and Depression : A  
34. Comparison Between Renal Transplant Recipients and Hemodialysis Patients, 
1084, 1082–1084. doi:10.1016/j.transproceed.2007.03.088 
35. Kemper, M. J., Spartà, G., Laube, G. F., Miozzari, M., & Neuhaus, T. J. 
(2003). Neuropsychologic side-effects of tacrolimus in pediatric renal 
transplantation. Clinical Transplantation, 17(2), 130–134. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12709079 
36. Kornfeld, D. S. (2002). Consultation-liaison psychiatry: contributions to 
medical practice. The American journal of psychiatry, 159(12), 1964–72. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12450941 
37. Lipowski, Z. J. (1986). Consultation-liaison psychiatry: the first half century. 
General Hospital Psychiatry, 8(5), 305–315. 
38. Mart, A. (2006). The Influence of Posttransplant Anxiety on the Long-Term, 
2408, 2406–2408. doi:10.1016/j.transproceed.2006.08.069 
39. Matas, A. J., Humar, A., Gillingham, K. J., Payne, W. D., Gruessner, R. W. 
G., Kandaswamy, R., Dunn, D. L., et al. (2002). Five preventable causes of 
 
90 
kidney graft loss in the 1990s: a single-center analysis. Kidney International, 
62(2), 704–714. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12110036 
40. Nogueira, E., Camara, N. O. S., Da Luz Fernandez, M., Salvador, F., Costa, F. 
P. M., Cenedeze, M. A., Ozaki, K. S., et al. (2010). Evolution of renal 
transplantation in India over the last four decades. NDT Plus, 3(2), iii538. 
doi:10.1093/ndtplus/sfp178 
41. Noohi, S., Khaghani-Zadeh, M., Javadipour, M., Assari, S., Najafi, M., 
Ebrahiminia, M., & Pourfarziani, V. (2007). Anxiety and depression are 
correlated with higher morbidity after kidney transplantation. Transplantation 
Proceedings, 39(4), 1074–1078. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/17524895 
42. Overbeck, I., Bartels, M., Decker, O., Harms, J., Hauss, J., & Fangmann, J. 
(2005). Changes in Quality of Life After Renal Transplantation, 1621, 1618–
1621. doi:10.1016/j.transproceed.2004.09.019 
43. Parkar, S. R., & Sawant, N. S. (2010). Liaison psychiatry and Indian research. 
Indian journal of psychiatry, 52(Suppl 1), S386–8. doi:10.4103/0019-
5545.69274 
44. Pascazio, L., Nardone, I. B., Clarici, A., Enzmann, G., Grignetti, M., Panzetta, 
G. O., & Vecchiet, C. (2010). Anxiety , Depression and Emotional Profile in 
Renal Transplant Recipients and Healthy Subjects : A Comparative Study. 
TPS, 42(9), 3586–3590. doi:10.1016/j.transproceed.2010.08.056 
45. Sathvik, B. S., Parthasarathi, G., Narahari, M. G., & Gurudev, K. C. (2008). 
An assessment of the quality of life in hemodialysis patients using the 
WHOQOL-BREF questionnaire. Indian journal of nephrology, 18(4), 141–9. 
doi:10.4103/0971-4065.45288 
46. Sezer, S., Mic, H., & Akman, B. (2003). Depression Levels Before and After 
Renal Transplantation, (45), 111–113. 
doi:10.1016/j.transproceed.2003.11.021 
 
91 
47. Shuto, H., Kataoka, Y., Kanaya, A., Matsunaga, K., Sueyasu, M., & Oishi, R. 
(1998). Enhancement of serotonergic neural activity contributes to 
cyclosporine-induced tremors in mice. European Journal of Pharmacology, 
341(1), 33–37. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9489853 
48. Sugawara, H., Nishimura, K., Kobayashi, S., Ishida, H., Tanabe, K., & 
Ishigooka, J. (2008). Paradoxical Depression in Renal Transplant Recipients. 
TPS, 40(10), 3448–3450. doi:10.1016/j.transproceed.2008.06.112 
49. Tsunoda, T., Yamashita, R., Kojima, Y., & Takahara, S. (2010). Risk factors 
for depression after kidney transplantation. Transplantation proceedings, 
42(5), 1679–81. doi:10.1016/j.transproceed.2009.12.073 
50. Vettath, R. E., Reddy, Y. N. V, Dutta, S., Singh, Z., Mathew, M., & Abraham, 
G. (2012). A multicenter cross-sectional study of mental and physical health 
depression in MHD patients. Indian journal of nephrology, 22(4), 251–6. 
doi:10.4103/0971-4065.101243 
51. Wulsin, L. R., Vaillant, G. E., & Wells, V. E. (1999). A systematic review of 
the mortality of depression. Psychosomatic Medicine, 61(1), 6–17. Retrieved 
from http://www.ncbi.nlm.nih.gov/pubmed/17888809 
 
BWônf£ RLYp Rôs 
BnYô[o   : 
TeúLtTô[o ùTVo  : 
RûXl×  : U]£ûRÜ úSô«u U]úNôo®u A±Ï±Ls  
                         ùRuTÓRÛm ARu RuûUÙm. 
BWônf£«u úSôdLm : 
RôeLs CkR UÚjÕY Bn®p LXkÕ ùLôsÞUôß AûZd¡ú\ôm. CkR 
BnYô]Õ GkRùYôÚ UÚjÕY RûXÂÓm CpXôRÕ. 
C§p EeLÞdÏ GkRùYôÚ BRôVúUô ApXÕ BTjúRô CÚdLôÕ. 
GeLs ûUVj§p SûPùT\ CÚdÏm Ko BWônf£dÏ EeLs JjÕûZl×m, 
Jl×RûXÙm úYiÓ¡ú\ôm. 
Ø¥ÜLû[ ApXÕ LÚjRLû[ ùY°«Óm úTôúRô ApXÕ 
BWônf£«uúTôúRô ReL[Õ ùTVûWúVô ApXÕ AûPVô[eLû[úVô 
ùY°«P UôhúPôm GuTûRÙm ùR¬®jÕd ùLôs¡ú\ôm. 
CkR BWônf£«p TeúLtTÕ ReLÞûPV ®ÚlTj§u úT¬p Rôu 
CÚd¡\Õ. úUÛm ¿eLs GkúSWØm CkR BWônf£«­ÚkÕ ©uYôeLXôm 
GuTûRÙm ùR¬®jÕdùLôs¡ú\ôm. 
CkR £\l×l T¬úNôRû]L°u Ø¥ÜLû[ Bn®u Ø¥®uúTôÕ 
ReLÞdÏ A±®lúTôm GuTûRÙm ùR¬®jÕd ùLôs¡ú\ôm. 
 
Jl×Rp T¥Ym 
GuTY¬u UL]ô¡V 
Guàm Sôu ‘U] úSô«u U]úNôo®u A±Ï±Ls ùRuTÓRÛm ARu 
RuûUÙm” Tt±V Ru]ôoYÚdLô] RLYp Rôû[ T¥jÕsú[u. CkR 
Bn®p TeÏùT\ Sôu RÏ§ Es[Yo Guß BnYô[oLs Ø¥ùYÓjRôp, 
Sôu Bn®p TeÏ ùTÚúYu. úUÛm BWônf£ ¨×QoLÞPu CkR 
Bn®u úSôdLm, CRu Y¯Øû\Ls G§oúSôdÏm TVeLs, TôÕLôTl× 
Y¯Øû\Ls, BnÜ TôPeLû[ Ï±jÕm, E¬ûULû[d TôÕLôlTÕ Ï±jÕm 
LXkÕûWVô¥Ùsú[u. G]dÏ GÝm úLs®Lû[d úLhÓ AYt±tÏ 
§Úl§LWUô] T§pLs A°dLlThPÕ, GÝjÕ êXUôLÜm T§pLs 
A°dLlTÓm GuTûR ×¬kÕ ùLôiÓsú[u. 
G]Õ ®ÚlTj§u úT¬úXúV Sôu CkR Bn®p TeúLt¡ú\u. Gu]ôp 
C§p TeúLtLôUp ®X¡d ùLôs[Üm ùNnVXôm GuTûR ×¬kÕ 
ùLôiÓsú[u. úUÛm GkR JÚ LôWQj§tLôLÜm, CkR Bn®­ÚkÕ 
Gu]ôp Sôu ®ÚlTlThPôp ®X¡d ùLôs[ Ø¥Ùm GuTûRÙm 
A±kÕsú[u. 
CkR Bn®p Sôu JÚ BnÜ ùNnVlTÓm STWôL CÚkRôp G]Õ 
E¬ûULs Ï±jÕ HúRàm úLs®Ls GÝm©]ôp. Sôu BWônf£Vô[oLû[ 
GkR úSWØm ùRôPo× ùLôiÓ NkúRLeLû[ ¨Yoj§ ùNnÕ ùLôsúYu. 
úUÛm CkR Bn®p JÚ TeúLtTô[o Gu\ Øû\«p NhPj§tÏ 
úRûYlTÓm NkRolTeLû[j R®W ©\ NUVeL°p CkR BnÜj ùRôPoTô] 
G]Õ AûPVô[m UÚjÕY BYQeLs Utßm RLYpLs WL£VUôL 
ûYdLlTh¥ÚdÏm GuTûR Sôu A±kÕùLôiÓsú[u. 
CkR BnÜ Utßm C§Ûs[ TVuLs Ï±jÕ Aû]jÕ RLYpLû[Ùm 
Sôu ØÝûUVôL A±kÕùLôiÓ, ARuT¥ BnÜ Y¯Øû\Lû[ 
úUtùLôs[ Sôu Jl×Rp A°d¡ú\u. CkR Jl×RpT¥Yj§p SLp 
Ju±û] Sôu ùTtßdùLôiúPu. 
TeúLtTô[o ùTVo  : 
ûLùVôlTm   : 
Sôs    : 
ØRuûU BnYô[o  : 
ûLùVôlTm   : 
Sôs    : 
The Mini-Mental State Exam
Patient___________________________________ Examiner ____________________________ Date____________
Maximum Score
Orientation
5 (   ) What is the (year) (season) (date) (day) (month)?
5 (   ) Where are we (state) (country) (town) (hospital) (floor)?
Registration
3 (   ) Name 3 objects: 1 second to say each.  Then ask the patient
all 3 after you have said them.  Give 1 point for each correct answer.  
Then repeat them until he/she learns all 3. Count trials and record.
Trials ___________
Attention and Calculation
5 (   ) Serial 7’s.  1 point for each correct answer.  Stop after 5 answers.
Alternatively spell “world” backward.
Recall
3 (   ) Ask for the 3 objects repeated above.  Give 1 point for each correct answer.
Language
2 (   ) Name a pencil and watch.
1 (   ) Repeat the following “No ifs, ands, or buts”
3 (   ) Follow a 3-stage command:
“Take a paper in your hand, fold it in half, and put it on the floor.”
1 (   ) Read and obey the following:  CLOSE YOUR EYES
1 (   ) Write a sentence.
1 (   ) Copy the design shown.
_____ Total Score
ASSESS level of consciousness along a continuum ____________
Alert   Drowsy   Stupor   Coma
"MINI-MENTAL STATE." A PRACTICAL METHOD FOR GRADING THE COGNITIVE STATE OF PATIENTS FOR THE CLINICIAN.
Journal of Psychiatric Research, 12(3): 189-198, 1975. Used by permission.
A series provided by 
The Hartford Institute for Geriatric Nursing
(hartford.ign@nyu.edu)
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WHOQOL-BREF 
 
The following questions ask how you feel about your quality of life, health, or other areas of 
your life. I will read out each question to you, along with the response options. Please choose 
the answer that appears most appropriate. If you are unsure about which response to give 
to a question, the first response you think of is often the best one. 
 
Please keep in mind your standards, hopes, pleasures and concerns. We ask that you think 
about your life in the last four weeks. 
 
  Very poor Poor Neither poor nor good  Good Very good 
1. How would you rate your 
quality of life? 1 2 3 4 5 
 
 
  Very 
dissatisfied Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
Satisfied Very satisfied 
2. How satisfied are you with your 
health? 1 2 3 4 5 
 
The following questions ask about how much you have experienced certain things in the last 
four weeks. 
  Not at all A little A moderate amount Very much 
An extreme 
amount 
3. To what extent do you feel that 
physical pain prevents you 
from 
doing what you need to do? 
5 4 3 2 1 
4. How much do you need any 
medical treatment to function 
in your daily life? 
5 4 3 2 1 
5. How much do you enjoy life? 1 2 3 4 5 
6. To what extent do you feel your 
life to be meaningful? 1 2 3 4 5 
 
  Not at all A little A moderate amount Very much Extremely 
7. How well are you able to 
concentrate? 1 2 3 4 5 
8. How safe do you feel in your 
daily life? 1 2 3 4 5 
9. How healthy is your physical 
environment? 1 2 3 4 5 
 
The following questions ask about how completely you experience or were able to do certain 
things in the last four weeks. 
  Not at all A little Moderately Mostly Completely 
10. Do you have enough energy for 
everyday life? 1 2 3 4 5 
11. Are you able to accept your 
bodily appearance? 1 2 3 4 5 
12. Have you enough money to 
meet your needs? 1 2 3 4 5 
13. How available to you is the 
information that you need in 
your day-to-day life? 
1 2 3 4 5 
14. To what extent do you have the 
opportunity for leisure 
activities? 
1 2 3 4 5 
 
 
  Very poor Poor Neither poor nor good  Good Very good 
15. How well are you able to get 
around? 1 2 3 4 5 
 
 
  Very 
dissatisfied Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
Satisfied Very satisfied 
16. How satisfied are you with your 
sleep? 1 2 3 4 5 
17. How satisfied are you with 
your ability to perform your 
daily living activities? 
1 2 3 4 5 
18. How satisfied are you with 
your capacity for work? 1 2 3 4 5 
19. How satisfied are you with 
yourself? 1 2 3 4 5 
 
20. How satisfied are you with your 
personal relationships? 1 2 3 4 5 
21. How satisfied are you with 
your sex life? 1 2 3 4 5 
22. How satisfied are you with the 
support you get from your 
friends? 
1 2 3 4 5 
23. How satisfied are you with the 
conditions of your living place? 1 2 3 4 5 
24. How satisfied are you with your 
access to health services? 1 2 3 4 5 
25. How satisfied are you with 
your transport? 1 2 3 4 5 
 
The following question refers to how often you have felt or experienced certain things in the 
last four weeks. 
  Never Seldom Quite often Very often Always 
26. How often do you have 
negative feelings such as blue 
mood, despair, anxiety, 
depression? 
5 4 3 2 1 
 
Do you have any comments about the assessment? 
 
 
 
 
 
[The following table should be completed after the interview is finished] 
 
Transformed scores*  Equations for computing domain scores Raw score 
4-20 0-100 
27. Domain 1 (6-Q3) + (6-Q4) + Q10 + Q15 + Q16 + Q17 + Q18 
      +      +     +    +    +    +   
a. = b: c: 
28. Domain 2 Q5 + Q6 + Q7 + Q11 + Q19 + (6-Q26) 
  +  +  +     +     +    
a. = b: c: 
29. Domain 3 Q20 + Q21 + Q22 
   +    +   
a. = b: c: 
30. Domain 4 Q8 + Q9 + Q12 + Q13 + Q14 + Q23 + Q24 + Q25 
  +  +   +    +    +    +    +   
a. = b: c: 
 
* See Procedures Manual, pages 13-15 
 



 
